LIPTA
DCI : AMLODIPINE+ATORVASTATIN
Dosage 5 mg/10 mg
Pharmaceutical form Coated tablet
Therapeutic class Cardiology-Engiology
P/30
Indications
This medication is indicated for the prevention of cardiovascular events for hypertensive patients with 3 associated cardiovascular risk factors, with normal to moderately high cholesterol without proven coronary disease, and in whom, according to the recommendations in force, the concomitant use of amlodipine and a low dose of atorvastatin is suitable. This medication should be used when the response to diet and other non-pharmacological measures is inadequate.
Download the leaflet
